Valneva

Valneva Initiates Phase 1/2 Clinical Study of Inactivated, Adjuvanted COVID-19 Vaccine Candidate
Valneva Initiates Phase 1/2 Clinical Study of Inactivated, Adjuvanted COVID-19 Vaccine Candidate
Drugs.com
Valneva
vaccines
clinical trials
COVID-19
VLA2001
Flag link:
Four Potential Biotech Market Movers to Watch Going into 2021
Four Potential Biotech Market Movers to Watch Going into 2021
BioSpace
INmune Bio
Valneva
CalciMedica
Vaxart
vaccines
COVID-19
pandemic
Flag link:
Valneva signs manufacturing partner to produce adjuvant for COVID-19 vaccine
Valneva signs manufacturing partner to produce adjuvant for COVID-19 vaccine
Fierce Pharma
Valneva
Dynavax
drug manufacturing
vaccines
COVID-19
Flag link:
Valneva signs $1.6B supply, development agreement with UK for coronavirus vaccine hopeful
Valneva signs $1.6B supply, development agreement with UK for coronavirus vaccine hopeful
Fierce Pharma
UK
Valneva
COVID-19
vaccines
Flag link:
Amid Covid-19 hunt, Pfizer adds Lyme disease vaccine in $308M deal with Valneva
Amid Covid-19 hunt, Pfizer adds Lyme disease vaccine in $308M deal with Valneva
Endpoints
Pfizer
Lyme disease
vaccines
Valneva
Flag link:
Lyme Disease Vaccine Could Be Ready In 4 to 5 Years
Lyme Disease Vaccine Could Be Ready In 4 to 5 Years
Forbes
Lyme disease
vaccines
Valneva
VLA015
Flag link:
Can a new Lyme disease vaccine overcome a history of distrust and failure?
Can a new Lyme disease vaccine overcome a history of distrust and failure?
Stat
Lyme disease
vaccines
drug development
LYMErix
VLA15
Valneva
Flag link:
Pfizer, Valneva stand to gain from Sanofi's C. diff vaccine flop: report
Pfizer, Valneva stand to gain from Sanofi's C. diff vaccine flop: report
Fierce Pharma
Pfizer
Valneva
Sanofi
C. difficile
vaccines
PF-06425090
Flag link: